isoxazoles has been researched along with 1-methyl-2-(3-pyridyl)azetidine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergström, M; Bivehed, H; Fasth, KJ; Långström, B; Nordberg, A; Ogren, M; Sihver, W; Watanabe, Y | 1 |
Bergström, M; Fasth, KJ; Långström, B; Lundqvist, H; Nordberg, A; Ogren, M; Sihver, W; Watanabe, Y | 1 |
2 other study(ies) available for isoxazoles and 1-methyl-2-(3-pyridyl)azetidine
Article | Year |
---|---|
In vitro evaluation of 11C-labeled (S)-nicotine, (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole, and (R,S)-1-methyl-2-(3-pyridyl)azetidine as nicotinic receptor ligands for positron emission tomography studies.
Topics: Animals; Azetidines; Binding Sites; Brain; Carbon Radioisotopes; Isoxazoles; Ligands; Male; Nicotine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Tomography, Emission-Computed | 1998 |
In vivo positron emission tomography studies on the novel nicotinic receptor agonist [11C]MPA compared with [11C]ABT-418 and (S)(-)[11C]nicotine in rhesus monkeys.
Topics: Animals; Azetidines; Brain; Carbon Radioisotopes; Cerebellum; Isoxazoles; Macaca mulatta; Nicotine; Organ Specificity; Pyrrolidines; Radiopharmaceuticals; Temporal Lobe; Thalamus; Tomography, Emission-Computed | 1999 |